$CFX : Hong Kong sector domestic leading chain related targets
Leading pharmaceutical biotechnology company acquired $CFX , and significant positive news is expected to come out afterwards, which may lead to speculation.
However, there are too many trapped positions above it, so it is not recommended to hold it for the medium to long term.
The project party will likely push the price up quickly and then rapidly decline, so don't rush to chase the rise.
Brothers without short-term trading experience should preferably not hold it easily.
